Skip to content

The Benefits of Early Initiation of Continual Renal Replacement Therapy in Patients With Severe Sepsis

The Benefits of Early Initiation of Continuous Renal Replacement Therapy (CRRT) in Patients With Severe Sepsis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03141112
Enrollment
200
Registered
2017-05-04
Start date
2016-08-31
Completion date
2020-12-31
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Sepsis

Brief summary

The study will evaluate the benefit of early initiation of CRRT in the initial phase of severe sepsis in patients admitted to the ICU. Primary evaluated end-point is 28-day mortality. Secondarily evaluated end-point is length of ICU-stay, length of stay in hospital, duration of mechanical ventilation. There are two groups. One group of participants with early CRRT initiation and another group with late CRRT initiation. Reference group no CRRT.

Detailed description

The aim is to determine the optimal timing of initiation of CRRT with respect to the degree and duration of acute kidney injury (AKI) in ICU patients. The CRRT parameters and the duration of therapy will be monitored, depending on initial biochemical and clinical values of the patient. Part of the study is the follow-up of patients with a 3-month delay.

Interventions

PROCEDURErenal replacement therapy

Sponsors

Radovan Uvizl
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* reaching criteria of severe sepsis, ICU admission

Exclusion criteria

* pregnant women, younger than 18 years, reaching contraindications for initiation of renal replacement therapy

Design outcomes

Primary

MeasureTime frameDescription
mortality28 daysyes/no

Secondary

MeasureTime frameDescription
duration of mechanical ventilation28 daysdays of mechanical ventilation including weening

Other

MeasureTime frameDescription
length of stay3 monthslength of stay in hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026